Can B Corp (CANB)

[sleekscape]

Canbiola, Inc. Uplists to OTCQB Venture Market

https://finance.yahoo.com/news/canbiola-inc-uplists-otcqb-venture-143000221.html

HICKSVILLE, NY, Nov. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB), is pleased to announce the Company has been approved for up-listing its common shares for trading on the OTCQB Venture Market, a US trading platform that is operated by the OTC Markets Group in New York. The Company will trade on the OTCQB under symbol "CANB". Canbiola is a manufacturer of proprietary CBD non-psychoactive cannabinoid products extracted from the hemp plant focused on the commercial development of hemp and CBD-based products for both the medical and consumer market. Its product line includes hemp oil drops (of various concentrations), muscle and joint salves, and manufacturing of its new CBD CryoGel pain relief product.

The OTCQB is the premier marketplace for entrepreneurial and development stage US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. The ability to have the Company's shares electronically transferred between brokerages in the US is significantly more convenient and reduces the costs incurred in trading shares. When shares are able to trade electronically, existing investors benefit from greater liquidity and execution speeds, while opening the door to new investors that may have been previously been restricted from the Company's shares.

According to Canbiola’s CEO Marco Alfonsi, "Listing on the OTCQB is part of a long-term strategy to introduce the Company to a broader audience and the timing of this listing complements the recent progress we have made with the release of several new products plus executing the agreement to acquire its manufacturing facility as a wholly owned subsidiary thereby directly controlling its own production.” Mr. Alfonsi added, "We expect our presence on the OTCQB to further enhance trading liquidity and provide additional exposure to US and institutional investors who are looking to align with progressive companies like ours which are focused on non-opioid-based all natural and organic compound products that contain 99.9% pure CBD."

Alfonsi concluded, “This is a very exciting time in the world of hemp and CBD and we are passionate about the potential to change people’s lives with our CBD products.”

About Canbiola, Inc.:

Canbiola, Inc. is a public company trading under symbol CANB.

Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. The company has already launched several products found at www.canbiola.com.